Li, D., Meng, D., & Niu, R. (2020). Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring miR-613. Cancer Manag Res.
Citación estilo ChicagoLi, Delong, Debin Meng, y Rungui Niu. "Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring MiR-613." Cancer Manag Res 2020.
Cita MLALi, Delong, Debin Meng, y Rungui Niu. "Exosome-Reversed Chemoresistance to Cisplatin in Non-Small Lung Cancer Through Transferring MiR-613." Cancer Manag Res 2020.
Precaución: Estas citas no son 100% exactas.